Volume 22 Number 4 Child & Adolescent Psychopharmacology ADELAIDE S. ROBB, M.D., EDITOR News CONTENTS CME Medical Marijuana in Children TEST ARTICLE 1 Medical Marijuana in Children and Adolescents: An Updated and Adolescents: Review for Psychopharmacologists An Updated Review for Psychopharmacologists Shane Shucheng Wong, M.D., and Timothy E. Wilens, M.D. 9 CME Post-Test The recent legalization of medical marijuana in many states has led to its in- creasing accessibility as a potential medical treatment in pediatric populations. As a result, there is a need among psychopharmacologists to understand the evidence base for its use as a medical treatment in children and adolescents. The purpose of this article is to systematically review the empirical literature on the medical benefits of marijuana in children and adolescent patient populations. In total, after a review of 2,744 citations, 22 articles met inclusion criteria detailing 23 studies, with a total sample of 881 participants. Six randomized controlled IMPORTANT NOTICE: This publication is intended to provide trials, 5 retrospective chart reviews, 5 case reports, 4 open-label trials, 2 parent accurate and authoritative information regarding the subject mat- ter covered. It is sold with the understanding that the publisher is surveys, and 1 case series were
Child and Adolescent Psychopharmacology News – Guilford Press
Published: Aug 1, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera